| Announce Date | 10/29/2025 | 
| EPS Normalized Actual | $0.28 (Beat by $0.106) | 
| EPS GAAP Actual | $0.28 (Beat by $0.106) | 
| Revenue Actual | $0.14011B | 
| Revenue Surprise | Beat by $140.11M | 
| Announce Date | 12/31/1969 (Pre-Market) | 
| EPS Normalized Estimate | $ | 
| EPS GAAP Estimate | $ | 
| Revenue Estimate | $0B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 1.976 | 6.6 | 1.56954 | 2.41914 | 1 | 
| Dec 2028 | 1.7739 | 7.35 | 1.3052 | 2.34587 | 1 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0757 | 0.0757 | 0.14011B | -1.43% | 140.11M | 
| FQ2 2025 (Jun 2025) | 0.35 | 0.35 | 0.128316B | -16.95% | 128.32M | 
| FQ1 2025 (Mar 2025) | 0.27 | 0.27 | 0.118574B | -23.03% | 118.57M | 
| FQ4 2024 (Dec 2024) | 0.34 | 0.34 | 0.131391B | -8.3% | 131.39M | 
| FQ3 2024 (Sep 2024) | 0.22 | 0.22 | 0.142107B | 7.42% | 142.11M | 
| FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 0.150066B | -1.99% | 150.07M | 
| FQ1 2024 (Mar 2024) | 0.29 | 0.29 | 0.145876B | 9.12% | 145.88M | 
| FQ4 2023 (Dec 2023) | 0.22 | 0.22 | 0.142292B | -17.99% | 142.29M | 
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 0.5601 | -- | 0.53852 | 0.58168 | 1 | 
| FQ3 2029 (Sep 2029) | 0.5575 | -- | 0.53602 | 0.57898 | 1 | 
| FQ2 2029 (Jun 2029) | 0.5463 | -- | 0.52525 | 0.56735 | 1 | 
| FQ1 2029 (Mar 2029) | 0.5354 | -- | 0.51477 | 0.55603 | 1 | 
| FQ4 2028 (Dec 2028) | 0.55136 | -- | 0.53012 | 0.5726 | 1 | 
| FQ3 2028 (Sep 2028) | 0.54879 | -- | 0.52765 | 0.56993 | 1 | 
| FQ2 2028 (Jun 2028) | 0.53756 | -- | 0.51685 | 0.55827 | 1 | 
| FQ1 2028 (Mar 2028) | 0.4293 | -- | 0.42253 | 0.43361 | 2 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 0.17B | -- | 0.17B | 0.18B | 1 | 
| FQ3 2029 (Sep 2029) | 0.17B | -- | 0.17B | 0.18B | 1 | 
| FQ2 2029 (Jun 2029) | 0.17B | -- | 0.16B | 0.17B | 1 | 
| FQ1 2029 (Mar 2029) | 0.17B | -- | 0.16B | 0.17B | 1 | 
| FQ4 2028 (Dec 2028) | 0.16B | -- | 0.16B | 0.17B | 1 | 
| FQ3 2028 (Sep 2028) | 0.16B | -- | 0.16B | 0.17B | 1 | 
| FQ2 2028 (Jun 2028) | 0.16B | -- | 0.16B | 0.17B | 1 | 
| FQ1 2028 (Mar 2028) | 0.17B | -- | 0.17B | 0.17B | 1 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0757 | 0.0757 | 100% | |
| FQ2 2025 (Jun 2025) | 0.35 | 0.35 | 100% | |
| FQ1 2025 (Mar 2025) | 0.27 | 0.27 | 100% | |
| FQ4 2024 (Dec 2024) | 0.34 | 0.34 | 100% | |
| FQ3 2024 (Sep 2024) | 0.22 | 0.22 | 100% | |
| FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 100% | |
| FQ1 2024 (Mar 2024) | 0.29 | 0.29 | 100% | |
| FQ4 2023 (Dec 2023) | 0.22 | 0.22 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.14B | $140.11M | 100% | 
| FQ2 2025 (Jun 2025) | $0B | $0.13B | $128.32M | 100% | 
| FQ1 2025 (Mar 2025) | $0B | $0.12B | $118.57M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $0.13B | $131.39M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $0.14B | $142.11M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $0.15B | $150.07M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $0.15B | $145.88M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $0.14B | $142.29M | 100% |